Emergent Biosolutions Inc Cash Flow Reinvestment Rate
Emergent Biosolutions Inc cash flow reinvestment rate. Emergent Biosolutions Inc (EBS) has a Cash Flow Reinvestment Rate of 0.04x as of June 2026, reinvesting $2.10 Million (capex $2.10 Million ) from operating cash flow of $56.10 Million. Explore Emergent Biosolutions Inc (EBS) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Emergent Biosolutions Inc (2004–2025)
Cash flow reinvestment rate of Emergent Biosolutions Inc from 2004 to 2025. Historical reinvestment intensity for Emergent Biosolutions Inc across 19 annual periods. Explore reinvestment intensity of Emergent Biosolutions Inc to see what proportion of operating cash flow is directed to capital expenditures.
Emergent Biosolutions Inc Cash Flow Reinvestment Rate by Year (2004–2025)
Emergent Biosolutions Inc cash flow reinvestment rate by year from 2004 to 2025. Year-by-year capital reinvestment analysis for Emergent Biosolutions Inc. For the full cash flow conversion analysis, see Emergent Biosolutions Inc operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.08x | $13.80 Million | $170.60 Million | $13.80 Million | ▼ -96.8% |
| 2024 | 2.52x | $148.10 Million | $58.70 Million | $22.90 Million | ▲ +80.0% |
| 2021 | 1.40x | $450.00 Million | $321.10 Million | $225.00 Million | ▲ +156.9% |
| 2020 | 0.55x | $292.90 Million | $536.90 Million | $141.90 Million | ▼ -44.2% |
| 2019 | 0.98x | $183.80 Million | $188.00 Million | $86.90 Million | ▼ -95.8% |
| 2018 | 23.19x | $969.30 Million | $41.80 Million | $72.10 Million | ▲ +1483.7% |
| 2017 | 1.46x | $304.76 Million | $208.14 Million | $54.83 Million | ▼ -48.6% |
| 2016 | 2.85x | $152.51 Million | $53.49 Million | $76.26 Million | ▲ +182.9% |
| 2015 | 1.01x | $44.81 Million | $44.46 Million | $44.81 Million | ▲ +269.1% |
| 2014 | 0.27x | $30.67 Million | $112.32 Million | $30.67 Million | ▼ -37.0% |
| 2013 | 0.43x | $42.02 Million | $96.97 Million | $42.02 Million | ▼ -68.1% |
| 2012 | 1.36x | $53.84 Million | $39.64 Million | $53.84 Million | ▼ -63.3% |
| 2011 | 3.70x | $54.03 Million | $14.59 Million | $54.03 Million | ▲ +1567.5% |
| 2010 | 0.22x | $22.10 Million | $99.54 Million | $22.10 Million | ▼ -79.6% |
| 2009 | 1.09x | $33.29 Million | $30.51 Million | $33.29 Million | ▼ -61.6% |
| 2008 | 2.84x | $20.81 Million | $7.32 Million | $20.81 Million | ▲ +258.7% |
| 2007 | 0.79x | $43.97 Million | $55.45 Million | $43.97 Million | ▲ +412.9% |
| 2005 | 0.15x | $6.53 Million | $42.25 Million | $6.53 Million | ▼ -91.7% |
| 2004 | 1.86x | $17.07 Million | $9.20 Million | $17.07 Million | — |